TORONTO - Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public offering.
TORONTO - Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public offering.
The company says it expects to sell between 41.7 million and 50 million shares at a price between $20 and $24 per share.
Apotex seeks to raise C$1.2B in Toronto IPO, marking a major test for Canada's public markets
Drugmaker Apotex files for IPO showing revenue jump
Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data - Apogee Therapeutics (NASDAQ:
Aspen Pharmacare's share price surges after R27 billion APAC business sale
Apex Service sells minority stake to Apollo at $10 billion valuation, source says
Anthropic files to go public in a potentially trillion-dollar debut | CNN Business
Apogee lands Blackstone $800M royalty deal to move Dupixent rival toward Phase 3
Abivax share plunge may change deal outlook
AI giant Anthropic files to go public in U.S. | CBC News
AI firm Anthropic fires starting gun on $1 trillion float
Apotex Health Corp. filed for a Toronto Stock Exchange IPO that could raise up to C$1.2 billion, backed by C$3.5B in revenue and…
TORONTO - Apotex Health Corp. says it has filed a preliminary prospectus for an initial public offering that will see the…
Canadian generic drugmaker Apotex Health Corp. filed for an initial public offering in Toronto. Find out more.
Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.
Aspen Pharmacare Holdings has successfully completed the sale of its Asia Pacific business for R27 billion, resulting in a…
WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.
